Fenretinide promotes functional recovery and tissue protection after spinal cord contusion injury in mice

Journal of Neuroscience

Volumn 30, Issue 9, 2010, Pages 3220-3226

  López Vales, Rubèn ^a,c   Redensek, Adriana ^a   Skinner, Thomas A A ^a   Rathore, Khizr I ^a   Ghasemlou, Nader ^a   Wojewodka, Gabriella ^a   De Sanctis, Juan B ^b   Radzioch, Danuta ^a   David, Samuel ^a  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^c INSTITUT DE NEUROCIÈNCIES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; FENRETINIDE; MESSENGER RNA; POLYUNSATURATED FATTY ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CONTUSION; FEMALE; FUNCTIONAL ASSESSMENT; GENE EXPRESSION; IN VITRO STUDY; LIPID ANALYSIS; MICROGLIA; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SPINAL CORD INJURY; TISSUE INJURY;

EID: 77749313475     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.5770-09.2010     Document Type: Article

References (52)

1. Bao F, Chen Y, Dekaban GA, Weaver LC (2004) Early anti-inflammatory treatment reduces lipid peroxidation and protein nitration after spinal cord injury in rats. J Neurochem 88:1335-1344.
2. Bao F, Dekaban GA, Weaver LC (2005) Anti-CD11d antibody treatment reduces free radical formation and cell death in the injured spinal cord of rats. J Neurochem 94:1361-1373.
3. Basso DM, Fisher LC, Anderson AJ, Jakeman LB, McTigue DM, Popovich PG (2006) Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma 23:635-659.
4. Brown WJ, Chambers K, Doody A (2003) Phospholipase A2 (PLA2) enzymes in membrane trafficking: mediators of membrane shape and function. Traffic 4:214-221.
5. Caughey GE, Pouliot M, Cleland LG, James MJ (1997) Regulation of tumor necrosis factor-α and IL-1β synthesis by thromboxane A2 in nonadherent human monocytes. J Immunol 158:351-358.
6. Datta PK, Reddy RS, Lianos EA (2001) Effects of all-trans-retinoic acid (atRA) on inducible nitric oxide synthase (iNOS) activity and transforming growth factor beta-1 production in experimental anti-GBM antibody-mediated glomerulonephritis. Inflammation 25:351-359.
7. De Sanctis JB (1991) Differences in the enzymatic hydrolysis of a marine lipid concentrate MAXEPA TM in comparison with INTRALIPIDTM. Med Sci Res 19:335-337.
8. Dheen ST, Jun Y, Yan Z, Tay SS, Ling EA (2005) Retinoic acid inhibits expression of TNF-alpha and iNOS in activated rat microglia. Glia 50:21-31.
9. Donnelly DJ, Popovich PG (2008) Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol 209:378-388.
10. Endres S, von Schacky C (1996) n-3 polyunsaturated fatty acids and human cytokine synthesis. Curr Opin Lipidol 7:48-52.
11. Farooqui AA, Horrocks LA, Farooqui T (2007) Modulation of inflammation in brain: a matter of fat. J Neurochem 101:577-599.
12. Ferguson AR, Christensen RN, Gensel JC, Miller BA, Sun F, Beattie EC, Bresnahan JC, Beattie MS (2008) Cell death after spinal cord injury is exacerbated by rapid TNFα-induced trafficking of GluR2-lacking AMPARs to the plasma membrane. J Neurosci 28:11391-11400.
13. Floyd RA, Carney JM (1992) Free radical damage to protein and DNA: mechanisms involved and relevant observations on brain undergoing oxidative stress. Ann Neurol 32 [Suppl]:S22-S27.
14. Folch J, Lees M, Sloane StanleyGH (1957) Asimple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497-509.
15. Formelli F, Cavadini E, Luksch R, Garaventa A, Villani MG, Appierto V, Persiani S (2008) Pharmacokinetics of oral fenretinide in neuroblastoma patients: indications for optimal dose and dosing schedule also with respect to the active metabolite 4-oxo-fenretinide. Cancer Chemother Pharmacol 62:655-665.
16. Genovese T, Mazzon E, Rossi A, Di Paola R, Cannavò G, Muià C, Crisafulli C, Bramanti P, Sautebin L, Cuzzocrea S (2005) Involvement of 5-lipoxygenase in spinal cord injury. J Neuroimmunol 166:55-64.
17. Genovese T, Mazzon E, Crisafulli C, Di Paola R, Muià C, Bramanti P, Cuzzocrea S (2006) Immunomodulatory effects of etanercept in an experimental model of spinal cord injury. J Pharmacol Exp Ther 316:1006-1016.
18. Genovese T, Mazzon E, Crisafulli C, Di Paola R, Muià C, Esposito E, Bramanti P, Cuzzocrea S (2008) TNF-alpha blockage in a mouse model of SCI: evidence for improved outcome. Shock 29:32-41.
19. Ghasemlou N, Kerr BJ, David S (2005) Tissue displacement and impact force are important contributors to outcome after spinal cord contusion injury. Exp Neurol 196:9-17.
20. Guilbault C, De Sanctis JB, Wojewodka G, Saeed Z, Lachance C, Skinner TA, Vilela RM, Kubow S, Lands LC, Hajduch M, Matouk E, Radzioch D (2008) Fenretinide corrects newly found ceramide deficiency in cystic fibrosis. Am J Respir Cell Mol Biol 38:47-56.
21. Guilbault C, Wojewodka G, Saeed Z, Hajduch M, Matouk E, De Sanctis JB, Radzioch D (2009) Cystic fibrosis fatty acid imbalance is linked to ceramide deficiency and corrected by fenretinide. Am J Respir Cell Mol Biol 41:100-106.
22. Hains BC, Yucra JA, Hulsebosch CE (2001) Reduction of pathological and behavioral deficits following spinal cord contusion injury with the selective cyclooxygenase-2 inhibitor NS-398. J Neurotrauma 18:409-423.
23. Hall ED, Braughler JM (1986) Role of lipid peroxidation in post-traumatic spinal cord degeneration: a review. Cent Nerv Syst Trauma 3:281-294.
24. Huang WL, King VR, Curran OE, Dyall SC, Ward RE, Lal N, Priestley JV, Michael-Titus AT (2007) A combination of intravenous and dietary docosahexaenoic acid significantly improves outcome after spinal cord injury. Brain 130:3004-3019.
25. Jones TB, McDaniel EE, Popovich PG (2005) Inflammatory-mediated injury and repair in the traumatically injured spinal cord. Curr Pharm Des 11:1223-1236.
26. King VR, Huang WL, Dyall SC, Curran OE, Priestley JV, Michael-Titus AT (2006) Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat. J Neurosci 26:4672-4680.
27. Kwon BK, Tetzlaff W, Grauer JN, Beiner J, Vaccaro AR (2004) Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J 4:451-464.
28. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
29. Lykkesfeldt J (2007) Malonyldialdehyde as a biomarker of oxidative damage to lipids caused by smoking. Clin Chim Acta 380:50-58.
30. Malone W, Perloff M, Crowell J, Sigman C, Higley H (2003) Fenretinide: a prototype cancer prevention drug. Expert Opin Investig Drugs 12:1829-1842.
31. Mehta K, McQueen T, Tucker S, Pandita R, Aggarwal BB (1994) Inhibition by all-trans-retinoic acid of tumor necrosis factor and nitric oxide production by peritoneal macrophages. J Leukoc Biol 55:336-342.
32. Mey J, J Morassutti D, Brook G, Liu RH, Zhang YP, Koopmans G, McCaffery P (2005) Retinoic acid synthesis by a population of NG2-positive cells in the injured spinal cord. Eur J Neurosci 21:1555-1568.
33. Montes de Oca M, Loeb E, Torres SH, De Sanctis J, Hernández N, Tálamo C (2008) Peripheral muscle alterations in non-COPD smokers. Chest 133:13-18.
34. Murakami M, Nakatani Y, Atsumi G, Inoue K, Kudo I (1997) Regulatory functions of phospholipase A2. Crit Rev Immunol 17:225-283.
35. Niehaus WG Jr, Samuelsson B (1968) Formation of malonulaldehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur J Biochem 6:126-130.
36. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358.
37. Pineau I, Lacroix S (2007) Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. J Comp Neurol 500:267-285.
38. Popovich PG, Longbrake EE (2008) Can the immune system be harnessed to repair the CNS? Nat Rev Neurosci 9:481-493.
39. Resnick DK, Graham SH, Dixon CE, Marion DW (1998) Role of cyclooxygenase 2 in acute spinal cord injury. J Neurotrauma 15:1005-1013.
40. Ribotta MG, Provencher J, Feraboli-Lohnherr D, Rossignol S, Privat A, Orsal D (2000) Activation of locomotion in adult chronic spinal rats is achieved by transplantation of embryonic raphe cells reinnervating a precise lumbar level. J Neurosci 20:5144-5152.
41. Rocha PN, Plumb TJ, Coffman TM (2003) Eicosanoids: lipid mediators of inflammation in transplantation. Springer Semin Immunopathol 25:215-227.
42. Saeed Z, Guilbault C, De Sanctis JB, Henri J, Marion D, St-Arnaud R, Radzioch D (2008) Fenretinide prevents the development of osteoporosis in Cftr-KO mice. J Cyst Fibros 7:222-230.
43. Sarsilmaz M, Songur A, Ozyurt H, Kuş I, Ozen OA, Ozyurt B, Söǧüt S, Akyol O (2003) Potential role of dietary omega-3 essential fatty acids on some oxidant/antioxidant parameters in rats' corpus striatum. Prostaglandins Leukot Essent Fatty Acids 69:253-259.
44. Saura J, Tusell JM, Serratosa J (2003) High-yield isolation of murine microglia by mild trypsinization. Glia 44:183-189.
45. Schwab JM, Chiang N, Arita M, Serhan CN (2007) Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447:869-874.
46. Serhan CN, Chiang N, Van Dyke TE (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8:349-361.
47. Smith WL, Dewitt DL (1996) Prostaglandin endoperoxide H synthases-1 and -2. Adv Immunol 62:167-215.
48. Torrisi R, Decensi A (2000) Fenretinide and cancer prevention. Curr Oncol Rep 2:263-270.
49. Xu W, Chi L, Xu R, Ke Y, Luo C, Cai J, Qiu M, Gozal D, Liu R (2005) Increased production of reactive oxygen species contributes to motor neuron death in a compression mouse model of spinal cord injury. Spinal Cord 43:204-213.
50. Yang L, Blumbergs PC, Jones NR, Manavis J, Sarvestani GT, Ghabriel MN (2004) Early expression and cellular localization of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in human traumatic spinal cord injury. Spine (Phila Pa 1976) 29:966-971.
51. Yang L, Jones NR, Blumbergs PC, Van Den Heuvel C, Moore EJ, Manavis J, Sarvestani GT, Ghabriel MN (2005) Severity-dependent expression of pro-inflammatory cytokines in traumatic spinal cord injury in the rat. J Clin Neurosci 12:276-284.
52. Ye YZ, Strong M, Huang ZQ, Beckman JS (1996) Antibodies that recognize nitrotyrosine. Methods Enzymol 269:201-209.